Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 7, 2011, Pages 1203-1211

  Hentschel, Maria ^a   Appold, Steffen ^a   Schreiber, Andreas ^b   Abolmaali, Nasreddin ^a   Abramyuk, Andrij ^a   Dörr, Wolfgang ^a   Kotzerke, Joerg ^a   Baumann, Michael ^a   Zöphel, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Chemoradiotherapy; FDG PET; Head and neck cancer; Outcome; Prognostic marker

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER CONTROL; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROGNOSIS; RADIATION DOSE DISTRIBUTION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 79958024281     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1759-3     Document Type: Article

References (42)

1. DI Conway M Hashibe P Boffetta INHANCE consortium V Wunsch-Filho J Muscat, et al. 2009 Enhancing epidemiologic research on head and neck cancer: INHANCE-the international head and neck cancer epidemiology consortium Oral Oncol 45 743 746 19442571 10.1016/j.oraloncology.2009.02.007
2. J Kotzerke L Oehme O Lindner D Hellwig Arbeitsausschuss PET der DGN 2010 Positron emission tomography 2008 in Germany-results of the query and current status Nuklearmedizin 49 58 64 20198277 10.3413/nukmed-0203 1:STN:280: DC%2BC3c3hvFWrsg%3D%3D
3. R Hustinx G Lucignani 2010 PET/CT in head and neck cancer: an update Eur J Nucl Med Mol Imaging 37 645 651 20187296 10.1007/s00259-009-1365-9
4. EG Troost DA Schinagl J Bussink WJ Oyen JH Kaanders 2010 Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours Radiother Oncol 96 328 334 20708808 10.1016/j.radonc.2010.07.017
5. M MacManus U Nestle KE Rosenzweig I Carrio C Messa O Belohlavek, et al. 2009 Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 85 94 19100641 10.1016/j.radonc.2008.11.008
6. F Denis P Garaud E Bardet M Alfonsi C Sire T Germain, et al. 2004 Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 69 76 14657228 10.1200/JCO.2004.08.021 (Pubitemid 41095116)
7. JP Malone MA Gerberi S Vasireddy LF Hughes K Rao B Shevlin, et al. 2009 Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography Arch Otolaryngol Head Neck Surg 135 1119 1125 19917925 10.1001/archoto.2009.152
8. M Yao RB Smith HT Hoffman GF Funk M Lu Y Menda, et al. 2009 Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report Int J Radiat Oncol Biol Phys 74 9 14 18930358 10.1016/j.ijrobp.2008.07. 019 1:CAS:528:DC%2BD1MXktl2jsb4%3D
9. BJ Moeller V Rana BA Cannon MD Williams EM Sturgis LE Ginsberg, et al. 2009 Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer J Clin Oncol 27 2509 2515 19332725 10.1200/JCO.2008.19.3300
10. J Kao HL Vu EM Genden B Mocherla EE Park S Packer, et al. 2009 The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer Cancer 115 4586 4594 19544537 10.1002/cncr.24493
11. SW Lee SY Nam KC Im JS Kim EK Choi SD Ahn, et al. 2008 Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 211 216 18237806 10.1016/j.radonc.2008.01.009 1:CAS:528:DC%2BD1cXlslygurs%3D
12. YM Seol BR Kwon MK Song YJ Choi HJ Shin JS Chung, et al. 2010 Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy Acta Oncol 49 201 208 20100156 10.3109/02841860903440270 1:CAS:528:DC%2BC3cXht1Snsr0%3D
13. X Geets M Tomsej JA Lee T Duprez E Coche G Cosnard, et al. 2007 Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy Radiother Oncol 85 105 115 17562346 10.1016/j.radonc.2007.05.010 (Pubitemid 47570061)
14. K Zoephel S Appold N Abolmaali 2008 PET / CT-basierte Bestrahlungsplanung bei Patienten mit Kopf-Hals-Tumoren Nuklearmedizin 31 55 59 10.1055/s-2008-1004621
15. M Hentschel S Appold A Schreiber A Abramyuk N Abolmaali J Kotzerke, et al. 2009 Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy Int J Radiat Biol 85 796 804 19728194 10.1080/ 09553000903039180 1:CAS:528:DC%2BD1MXhtVOmsbrE
16. V Budach M Stuschke W Budach M Baumann D Geismar G Grabenbauer, et al. 2005 Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial J Clin Oncol 23 1125 1135 15718308 10.1200/JCO.2005.07.010 1:CAS:528:DC%2BD2MXitl2gtbY%3D (Pubitemid 46202268)
17. V Grégoire P Levendag KK Ang J Bernier M Braaksma V Budach, et al. 2003 CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines Radiother Oncol 69 227 236 14644481 10.1016/j.radonc.2003.09.011 (Pubitemid 37485996)
18. R Boellaard MJ O'Doherty WA Weber FM Mottaghy MN Lonsdale SG Stroobants, et al. 2010 FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 Eur J Nucl Med Mol Imaging 37 181 200 19915839 10.1007/s00259-009-1297-4
19. U Nestle J Kotzerke 2009 PTV-PET traced volume? Nuklearmedizin 48 127 129 19739334 1:STN:280:DC%2BD1Mnht1eltg%3D%3D
20. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall; 1984.
21. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
22. K Bruechner R Bergmann A Santiago B Mosch A Yaromina F Hessel, et al. 2009 Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation Int J Radiat Biol 85 772 780 19657862 10.1080/09553000903043067 1:CAS:528:DC%2BD1MXhtVOmsb3N
23. K Kubota R Kubota S Yamada 1993 FDG accumulation in tumor tissue J Nucl Med 34 419 421 8441033 1:STN:280:DyaK3s7nvF2ltw%3D%3D
24. M Westerterp GW Sloof OS Hoekstra FJ Ten Kate GA Meijer JB Reitsma, et al. 2008 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome J Cancer Res Clin Oncol 134 227 236 17653575 10.1007/s00432-007-0275-0 (Pubitemid 350234068)
25. E Brun E Kjellén J Tennvall T Ohlsson A Sandell R Perfekt, et al. 2002 FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 127 135 11891942 10.1002/hed.10037 (Pubitemid 34111509)
26. L Sokoloff M Reivich C Kennedy MH Des Rosiers CS Patlak KD Pettigrew, et al. 1977 The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 897 916 864466 10.1111/j.1471-4159.1977. tb10649.x 1:CAS:528:DyaE2sXltlWiuro%3D (Pubitemid 8098854)
27. CG Rhodes RJ Wise JM Gibbs RS Frackowiak J Hatazawa AJ Palmer, et al. 1983 In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas Ann Neurol 14 614 626 6606389 10.1002/ana.410140604 1:CAS:528:DyaL2cXmsF2ktA%3D%3D (Pubitemid 14211607)
28. L Geworski BO Knoop M de Wit V Ivancević R Bares DL Munz 2002 Multicenter comparison of calibration and cross calibration of PET scanners J Nucl Med 43 635 639 11994527 (Pubitemid 34507115)
29. M Soret SL Bacharach I Buvat 2007 Partial-volume effect in PET tumor imaging J Nucl Med 48 932 945 17504879 10.2967/jnumed.106.035774 (Pubitemid 46909922)
30. DL Schwartz J Rajendran B Yueh MD Coltrera M Leblanc J Eary, et al. 2004 FDG-PET prediction of head and neck squamous cell cancer outcomes Arch Otolaryngol Head Neck Surg 130 1361 1367 15611393 10.1001/archotol.130.12.1361 (Pubitemid 39603296)
31. SY Kim JL Roh MR Kim JS Kim SH Choi SY Nam, et al. 2007 Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx J Nucl Med 48 752 757 17475963 10.2967/jnumed.107.039610 (Pubitemid 47604975)
32. AS Allal DO Slosman T Kebdani M Allaoua W Lehmann P Dulguerov 2004 Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose Int J Radiat Oncol Biol Phys 59 1295 1300 15275712 10.1016/j.ijrobp.2003.12.039 1:CAS:528:DC%2BD2cXmtVWhsLk%3D (Pubitemid 38954050)
33. G Giovacchini M Picchio S Schipani C Landoni L Gianolli V Bettinardi, et al. 2009 Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer Tumori 95 177 184 19579863
34. KM Greven DW Williams III WF McGuirt Sr BA Harkness RB D'Agostino Jr JW Keyes Jr, et al. 2001 Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck 23 942 946 11754497 10.1002/hed.1136 1:STN:280:DC%2BD38%2FgtVamuw%3D%3D (Pubitemid 32977536)
35. MR Vernon M Maheshwari CJ Schultz MA Michel SJ Wong BH Campbell, et al. 2008 Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma Int J Radiat Oncol Biol Phys 70 678 684 18262086 10.1016/j.ijrobp.2007.10.044 (Pubitemid 351199732)
36. C Schütze R Bergmann A Yaromina F Hessel J Kotzerke J Steinbach, et al. 2007 Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice Radiother Oncol 83 311 315 17502117 10.1016/j.radonc.2007.04.033 (Pubitemid 46915542)
37. DA Schinagl WV Vogel AL Hoffmann JA van Dalen WJ Oyen JH Kaanders 2007 Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer Int J Radiat Oncol Biol Phys 69 1282 1289 17967318 10.1016/j.ijrobp.2007.07.2333 1:CAS:528:DC%2BD2sXht1aktb3I (Pubitemid 47625859)
38. MK Chung HS Jeong SG Park JY Jang YI Son JY Choi, et al. 2009 Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res 15 5861 5868 19737951 10.1158/1078-0432.CCR-08-3290 1:CAS:528:DC%2BD1MXhtFars7rM
39. TH La EJ Filion BB Turnbull JN Chu P Lee K Nguyen, et al. 2009 Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 1335 1341 19289263 10.1016/j.ijrobp.2008.10.060
40. C Greco SA Nehmeh H Schöder M Gönen B Raphael HE Stambuk, et al. 2008 Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer Am J Clin Oncol 31 439 445 18838879 10.1097/COC.0b013e318168ef82
41. TM Blodgett MB Fukui CH Snyderman BF Branstetter BM McCook DW Townsend, et al. 2005 Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake Radiographics 25 897 912 16009814 10.1148/rg.254035156 (Pubitemid 41196928)
42. MB Fukui TM Blodgett CH Snyderman JJ Johnson EN Myers DW Townsend, et al. 2005 Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging Radiographics 25 913 930 16009815 10.1148/rg.254045136 (Pubitemid 41196929)